Johnson & Johnson reduced and 86% of holidays against COVID-19 and Estados Unidos la semana que viene

Viales con una pegatina en la que se lee:
Viales con una pegatina en la que se lee: “COVID-19 / Vacuna contra el coronavirus / Sólo inyección” y una jeringa médica ante el logotipo de Johnson & Johnson

Johnson & Johnson will reduce by 86 the dose of its vaccine against COVID-19 that will be integrated into the United States on weekdays. The information is based on the data base of the Centers for Control and Prevention of Diseases (CDC, by its English seal), and aims to slow down the fluid inoculation campaign that is taking place since mid-summer in North America.

The distribution of the inoculum has been inconsistent since the pharmaceutical industry launched its first batch in March, sending 2.8 million doses throughout the country in advance of 400,000 during the following weeks.

The weekly pass rate increased from 1.9 million and this week the figure was raised to 4.9 million. Pero the week that this number will be reduced to only 700,000.

The distribution at the time of production was made after the federal officials reported that there was a human error in Emergent BioSolutions, a manufacturer that had been manufacturing Johnson & Johnson vehicles, had received more than 15 million doses.

This confusion led the regulators to withdraw the authorization of the plant’s production lines and that the Biden administration would merge Johnson & Johnson into the plant’s cargo. However, it would be difficult to determine with certainty how much the problems in the Baltimore factory will fluctuate in the total fluctuations in the distribution of vacancies.

Federal administrators verdeel lasdosis in all countries following the adult population of each state. This means that California surpasses only part of the reduction, after receiving 572,700 vacancies in the last days, only receiving 67,600 next week.

In Texas, the assignment will be reduced to 46,300 of 392,100; Florida, which received 313,200 vacancies this week, will receive only 37,000 of the next days. Guam, which received 16,900 doses, did not receive any weekly semesters.

However, Johnson & Johnson has made conservative estimates about the dose of production that it produces in principle, as well as its production targets in the United States, furthering what it promised in February and March.

The medicine against the covid-19 of Johnson & Johnson
The medicine against the covid-19 of Johnson & Johnson

The initial Johnson & Johnson caretaker is assigned to the United States province of a Dutch plant and is embedded in a vertical calendar. This led the Biden administration to announce the health officials of the vacancies series changer.

But the federal officials hope that with the help of the Emergent factory, there will be a constant dose of dose from the company in April. Now, considering that this plant is not subject to authorization, the entry calendar is only slightly shorter.

Maryland Health Secretary -there is Baltimore- Dennis R. Schrader points out to the caretakers of the vacancies that the “significant reduction without notice is a surprise and a disappointment”. The state receives 78,300 vacancies less than the nearest week in comparison with the current.

The Governor of Ohio, Mike DeWine, said the owner said that the dose reduction was not the result of “what sucks in the factory”. The unit receives 151,600 vacancies less than the next week.

Notwithstanding the failures of Johnson & Johnson, in the United States are applying large number of doses of the Pfizer and Modern vehicles. According to the latest data from the CDC, there are an average of 112 million people in the United States, he received at least one dose of a vaccine, including an average of 66.2 million people who were completely inoculated (this is 20 per cent of the population) is the Johnson & Johnson single dose vaccine or the Pfizer / BioNTech dose series.

The New York Times.

SEGUIR LEYENDO:

A prognostic intelligence informant that the world pandemic post is marked by the climatic change and social fragmentation
Quantities of vacancies against the COVID and of which laboratories located in Chile are currently

Source